# Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis

> **NCT00831974** · PHASE2 · COMPLETED · sponsor: **AB Science** · enrollment: 23 (actual)

## Conditions studied

- Mastocytosis

## Interventions

- **DRUG:** masitinib (AB1010)
- **DRUG:** masitinib (AB1010)

## Key facts

- **NCT ID:** NCT00831974
- **Lead sponsor:** AB Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-02
- **Final completion:** —
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831974, "Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00831974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*